Concept:
Hereditary tubulopathies affecting renal electrolyte handling typically present with distinct urinary electrolyte excretion patterns, acid-base imbalances, and blood pressure profiles.
Gitelman syndrome is an autosomal recessive salt-wasting tubulopathy of the distal convoluted tubule (DCT) that mimics the chronic administration of thiazide diuretics.
Explanation:
• Gitelman syndrome is caused by loss-of-function mutations in the SLC12A3 gene, which encodes the thiazide-sensitive Sodium-Chloride Cotransporter (NCCT) in the distal convoluted tubule.
• Impaired NaCl reabsorption in the DCT increases distal sodium and fluid delivery to the collecting duct, stimulating aldosterone-mediated sodium reabsorption in exchange for potassium and hydrogen ion excretion, leading to hypokalemia and metabolic alkalosis.
• The two distinguishing laboratory hallmarks that differentiate Gitelman syndrome from Bartter syndrome are:
1. Severe Hypomagnesemia with renal magnesium wasting
2. Hypocalciuria (low urinary calcium excretion, urine calcium-to-creatinine ratio $<0.2$) due to enhanced passive calcium reabsorption in the DCT.
• Bartter syndrome (loop-diuretic phenotype affecting NKCC2/ROMK in thick ascending limb) presents earlier in infancy with polyhydramnios, severe failure to thrive, and hypercalciuria with nephrocalcinosis.
• Liddle syndrome is characterized by constitutive activation of ENaC, causing hypokalemic metabolic alkalosis accompanied by severe hypertension and low renin/aldosterone levels.
Final Answer:
The combination of normal blood pressure, hypokalemia, metabolic alkalosis, hypomagnesemia, and characteristic hypocalciuria is diagnostic of Gitelman syndrome.